The mechanism of action for Tookad involves its accumulation in the tumor tissue after administration. When the targeted area is exposed to near-infrared light, Tookad is activated, leading to the generation of ROS. These reactive oxygen species induce cell death and disrupt the blood vessels feeding the tumor, effectively starving the cancer cells of nutrients and oxygen. This dual action makes Tookad a potent option in combating tumor growth.